31 March 2020 | Statements

The Global Health Innovative Technology Fund and Unitaid collaboration to accelerate access to innovative solutions

Tokyo and Geneva – The Global Health Innovative Technology Fund (GHIT) and Unitaid have signed a collaboration framework that aims to increase awareness of and access to innovation and expertise in key areas such as malaria, tuberculosis and neglected tropical diseases.

In the context of achieving the health-related Sustainable Development Goals and universal health coverage, GHIT and Unitaid will use this new collaborative framework to coordinate actions to accelerate access to innovative solutions, focusing on products and technologies that can deliver the most impact on the ground and address the global health-related needs.

The framework will operate at a broad strategic level to support alignment between GHIT’s strength in product development and Unitaid’s expertise in promoting access to and scale-up of health innovations. It also creates a channel for continuous dialogue between the two parties as part of their goals to bring innovation to vulnerable and underserved populations as part of reaching universal health coverage.

The GHIT Fund is a Japan-based international public-private partnership fund (PPP) between the Government of Japan, multiple pharmaceutical companies, the Bill & Melinda Gates Foundation, Wellcome, and the United Nations Development Programme (UNDP). The GHIT Fund invests and manages an R&D portfolio of development partnerships aimed at neglected diseases, such as malaria, tuberculosis and neglected tropical diseases that afflict the world’s vulnerable and underserved populations. The GHIT Fund mobilizes the Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases, in collaboration with global partners.

For more information:

Martin HARVEY ALLCHURCH | +41 79 249 35 29 | harveym@unitaid.who.int

Bumpei Tamamura, bumpei.tamamura@ghitfund.org

View All News

Featured News

27 October 2021

WHO-Unitaid statement on the MPP licensing agreement for molnupiravir

Read More

06 October 2021

GAVI, Unitaid and the Global Fund welcome WHO recommendation for world’s first malaria vaccine

Read More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.